Clover Health Investments

Q2 FY2026 EarningsQ2 FY26 results significantly exceeded consensus expectations across all major financial metrics. Total revenue reached $743.2M (+56% YoY), beating the $728.3M estimate, driven by 49% YoY Medicare Advantage membership growth and improved Star Ratings for the PPO plan. GAAP Net Income of $28.0M far outperformed the $17.0M consensus, while Adjusted Net Income of $40.4M doubled expectations ($19.7M). Furthermore, the recent recalculation of 2026 Star Ratings to 4.5 Stars for both PPO and HMO contracts provides a massive tailwind for FY27 revenue.